Divis Laboratories Ltd | DIVI - Equity Capital And Reserves


Divis Laboratories Ltd reported INR167.61B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Aurobindo Pharma INR 378.91B 28.57B Mar/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Divis Laboratories Ltd INR 167.61B 13.48B Mar/2026
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Lupin INR 224.48B 28.16B Mar/2026
Moderna USD 7.41B 1.24B Mar/2026
Organon & Co USD 903M 151M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Tilray USD 1.58B 39.08M Sep/2025
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026